| Document Date: 2003-02-26 06:56:15
Open Document File Size: 67,50 KBShare Result on Facebook
City Rockville / / Company Dura / ABC / / Continent America / Europe / / Country Germany / Belgium / Turkey / United States / Netherlands / Italy / Portugal / United Kingdom / Spain / Greece / / / / IndustryTerm even approved products / clinical applications / tissue-based products / travel risk / / MedicalCondition person’s dementia / demyelinating disease / Variant Creutzfeldt-Jakob Disease / Creutzfeldt-Jakob Disease / Dementia / related documentable diseases / natural disease / increased CJD / CJD / cerebrovascular accident / stroke / neurological disease / non-transmissible dementia / toxic/metabolic dementia / head trauma / Traumatic neurological injuries / Variant Creutzfeld-Jakob Disease / brain tumor / brain tumors / Other Neurological Disease / / MedicalTreatment corneal transplants / / Organization Medical and Technical Committee America / Blood Centers / Food and Drug Administration / FDA / American Association of Blood Banks / / Person Judith Woll / / / Position Chair / Scientific / Docket Officer / Medical Director / physician / recipient and transplanting physician / / ProgrammingLanguage DC / / ProvinceOrState Maryland / / Region northern Europe / / Technology transplantation / stem cells / / URL www.americasblood.org_ / /
SocialTag |
FDA Docket No. 02D-0266 Page 3 of 4 Comments by America’s Blood Centers December 23, 2002